Professor Lars Dölken

Further involvements

• 25/03/2024

  • Poster
  • P 376

  The non-canonical MCMV m54.5 protein regulates cell cycle progression

   Virus replication strategies
• 25/03/2024

  • Poster
  • P 354

  Deciphering HSV-1 host shutoff in Air-Liquid interface models

   Virus replication strategies
• 25/03/2024

  • Poster
  • P 403

  Longitudinal assessment of T cell immunity to SARS-CoV-2 following a fourth COVID-19 vaccine dose using a whole blood-based IFN-gamma release assay

   Clinical and diagnostic virology
• 25/03/2024

  • Poster
  • P 255

  Deciphering pro- and antiviral factors for MCMV infection by heterogeneity sequencing

   Host cell factors
• 25/03/2024

  • Poster
  • P 228

  Cellular heterogeneity in respiratory viral infections: Comparative insights from SARS-CoV-2, RSV, IAV, and VACV

   Host cell factors
• 25/03/2024

  • Poster
  • P 435

  Building Blocks of Understanding: Constructing a Reverse Genetic Platform for Investigating SARS-CoV-2

   Respiratory viruses
• 27/03/2024

  09:15 – 09:30 12 Min. 3 Min.

  • Abstract talk
  • O 061

  pUL36 deubiquitinase activity disrupts the NHEJ pathway to promote HSV-1 infection

   Innate immunity
• 28/03/2024

  09:00 – 09:15 12 Min. 3 Min.

  • Abstract talk
  • O 087

  Fine mapping of SARS-CoV-2 RNA-protein interactions identifies negative-sense RNA binders and uncovers a role of NSP9 in priming viral RNA synthesis

   Virus replication strategies